New patent for Oyster Point drug TYRVAYA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for TYRVAYA
Annual Drug Patent Expirations for TYRVAYA

Tyrvaya is a drug marketed by Oyster Point Pharma and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.

TYRVAYA drug price trends.

This drug has thirty-two patent family members in eighteen countries.

The generic ingredient in TYRVAYA is varenicline tartrate. One supplier is listed for this compound. Additional details are available on the varenicline tartrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top